Zobrazeno 1 - 2
of 2
pro vyhledávání: '"François Pierre Combes"'
Publikováno v:
Pharmaceutical Research
Pharmaceutical Research, 2013, 30 (9), pp.2355-67. ⟨10.1007/s11095-013-1079-3⟩
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2013, 30 (9), pp.2355-67. ⟨10.1007/s11095-013-1079-3⟩
Pharmaceutical Research, 2013, 30 (9), pp.2355-67. ⟨10.1007/s11095-013-1079-3⟩
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2013, 30 (9), pp.2355-67. ⟨10.1007/s11095-013-1079-3⟩
When information is sparse, individual parameters derived from a non-linear mixed effects model analysis can shrink to the mean. The objective of this work was to predict individual parameter shrinkage from the Bayesian information matrix (M BF ). We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54038ff92552a0f087b040280e0af4a0
https://www.hal.inserm.fr/inserm-00849820/document
https://www.hal.inserm.fr/inserm-00849820/document
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 4, Pp 230-237 (2020)
Everolimus is currently approved in Europe as an adjunctive therapy for patients aged ≥ 2 years with tuberous sclerosis complex (TSC)–associated treatment‐refractory partial‐onset seizures, based on the EXIST‐3 study (NCT01713946) results.
Externí odkaz:
https://doaj.org/article/6e50ca11434940eab3b3d6f55bde136c
